Cite
HARVARD Citation
Santini, D. et al. (2013). Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?. Future oncology. pp. 1809-1811. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Santini, D. et al. (2013). Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?. Future oncology. pp. 1809-1811. [Online].